Pregled bibliografske jedinice broj: 1205202
Endemicity of OXA-23 and OXA-72 in clinical isolates of Acinetobacter baumannii from three neighbouring countries in Southeast Europe
Endemicity of OXA-23 and OXA-72 in clinical isolates of Acinetobacter baumannii from three neighbouring countries in Southeast Europe // Journal of Applied Genetics, 62 (2021), 2; 353-359 doi:10.1007/s13353-021-00612-9. (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1205202 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Endemicity of OXA-23 and OXA-72 in clinical
isolates of Acinetobacter baumannii from three
neighbouring countries
in Southeast Europe
(Endemicity of OXA-23 and OXA-72 in clinical
isolates of Acinetobacter baumannii from three
neighbouring countries in Southeast Europe)
Autori
Goić Barišić, Ivana ; Kovačić, Ana ; Medić, Deana ; Jakovac, Sanja ; Petrović, Tanja ; Tonkić, Marija ; Novak, Anita ; Rubić, Žana ; Radić, Marina ; Milosavljević, Biljana ; Hrenović, Jasna
Izvornik
Journal of Applied Genetics (1234-1983) 62
(2021), 2;
353-359
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Acinetobacter baumannii . Endemic oxacillinase . Croatia . Serbia . Bosnia and Herzegovina
Sažetak
According to the World Health Organization, bacterium Acinetobacter baumannii is the first on the critical priority list of pathogens in urgent need for new antibiotics. The increasing resistance of A. baumannii to the last-line treatment options, including carbapenems, is a global problem. We report the molecular epidemiology of 12 carbapenem-resistant clinical isolates of A. baumannii collected from hospitalised patients in three neighbouring countries in Southeast Europe: Croatia, Serbia, and Bosnia and Herzegovina, giving an insight into the molecular characterisation and evolutionary history of the acquisition of resistance genes. Besides the blaOXA-23 gene, the endemic presence of OXA-72 oxacillinase of the same origin for more than a decade as the leading mechanism of carbapenem resistance in Southeast Europe was confirmed. To the best of our knowledge, this is the first paper that investigates and analyses the phylogenetic association of the most commonmechanisms of resistance to carbapenems in clinical isolates of A. baumannii originating from three neighbouring countries in Southeast Europe.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
HRZZ-IP-2014-09-5656 - Prirodno stanište klinički značajnih Acinetobacter baumannii (NATURACI) (Hrenović, Jasna, HRZZ - 2014-09) ( CroRIS)
Ustanove:
KBC Split,
Medicinski fakultet, Split
Profili:
Anita Novak
(autor)
Marija Tonkić
(autor)
Ivana Goić Barišić
(autor)
Jasna Hrenović
(autor)
Ana Kovačić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE